speb/financial-data huggingface dataset:
CYRE3.SA income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Payables: 1003891000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 173528000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Prepaid Assets: 33214000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Pretax Income: 981616000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Properties: 0.00
CYRE3.SA cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 76188000.00
CYRE3.SA cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -200932000.00
CYRE3.SA cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1038701000.00
CYRE3.SA cash_flow (annual, 2022-12-31) — Purchase Of PPE: -99473000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 3678333000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 43474000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Rent And Landing Fees: 24890000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 24890000.00
CYRE3.SA cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1389816000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 371483000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Selling General And Administration: 766189000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Share Issued: 399742799.00
CYRE3.SA cash_flow (annual, 2022-12-31) — Stock Based Compensation: 0.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 7121744000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 6906753000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -6301080.00
CYRE3.SA income_statement (annual, 2022-12-31) — Tax Provision: 123025000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.12
CYRE3.SA balance_sheet (annual, 2022-12-31) — Taxes Receivable: 17813000.00
CYRE3.SA cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -119199000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Total Assets: 16560139000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Total Capitalization: 10482167000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Total Debt: 4854866000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 7699331000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Total Expenses: 4860196000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 8860808000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 7393144000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 5158946000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 913289000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Total Other Finance Cost: 19018000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 56010000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Total Unusual Items: -52509000.00
CYRE3.SA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -52509000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 416708000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 24012395.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Treasury Stock: 298085000.00
CYRE3.SA balance_sheet (annual, 2022-12-31) — Working Capital: 5465133000.00
CYRE3.SA income_statement (annual, 2023-12-31) — +Operating Expense: 1213937000.00
CYRE3.SA income_statement (annual, 2023-12-31) — +Total Revenue: 6252699000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Accounts Payable: 319474000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2857730000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -281955000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 1898849000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Basic Average Shares: 374921000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Basic EPS: 2.51
CYRE3.SA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 129013000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 8928000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Capital Expenditure: -140449000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Capital Stock: 3395744000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 241792000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 2703757000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -317126000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Cash Equivalents: 54957000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Cash Financial: 186835000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 9909000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Change In Inventory: 81666000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -258098000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -404958000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Change In Payable: 152908000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 2688000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Change In Receivables: -846248000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Change In Working Capital: -1308609000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Changes In Cash: 112779000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Common Stock: 3395744000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -317126000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 7690341000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Cost Of Revenue: 4209100000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Current Assets: 9768408000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Current Debt: 1405470000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1405470000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 107062000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Current Deferred Taxes Assets: 3843000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Current Deferred Taxes Liabilities: 180039000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Current Liabilities: 3454384000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Current Provisions: 58059000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Deferred Tax: 94093000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Depreciation: 67088000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 67088000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Diluted Average Shares: 374921000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Diluted EPS: 2.51
CYRE3.SA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 942090000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Dividends Payable: 223746000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 247367000.00
CYRE3.SA income_statement (annual, 2023-12-31) — EBIT: 1717485000.00
CYRE3.SA income_statement (annual, 2023-12-31) — EBITDA: 1784573000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — End Cash Position: 241792000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Financing Cash Flow: 151276000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Finished Goods: 3701083000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Free Cash Flow: -756135000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -565823000.00
CYRE3.SA income_statement (annual, 2023-12-31) — General And Administrative Expense: 411978000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Goodwill: 181854000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 187730000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Gross PPE: 146438000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Gross Profit: 2043599000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 34871000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Interest Expense: 455274000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 455274000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Interest Income: 32131000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Interest Income Non Operating: 32131000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -448468000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Inventory: 3701083000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Invested Capital: 12847879000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Investing Cash Flow: 577189000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 1898849000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 2439589000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Long Term Debt: 3752068000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3752068000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 2439589000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2028823000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 2439156000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Long Term Provisions: 88768000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 9377000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Minority Interest: 809485000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Minority Interests: -163610000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -10652000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Net Debt: 4915746000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Net Income: 942090000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 942090000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 1105700000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 942090000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 942090000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 1262211000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 1105700000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -15772000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Net Interest Income: -468602000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 470271000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 410766000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 410766000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -468602000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 166345000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Net PPE: 146438000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -124677000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 7502611000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 658739000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 2976000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 430579000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Normalized EBITDA: 1758672000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Normalized Income: 919038110.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Operating Cash Flow: -615686000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Operating Income: 829662000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Operating Revenue: 6252699000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 374920604.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Other Current Assets: 319495000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 267551000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Other Equity Interest: -72755000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 5876000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 616032000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1707055000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Other Operating Expenses: 68513000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Other Payable: 472786000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Other Properties: 128133000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Other Receivables: 107062000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 2461965000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Payables: 1066565000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 183437000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Prepaid Assets: 30526000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Pretax Income: 1262211000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Properties: 0.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 115040000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 4209100000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 67088000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Rent And Landing Fees: 23800000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 23800000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2028823000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Retained Earnings: 0.00
CYRE3.SA income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 459964000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Selling General And Administration: 871942000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Share Issued: 399742799.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 7690341000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 7502611000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 2849110.00
CYRE3.SA income_statement (annual, 2023-12-31) — Tax Provision: 156511000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.11
CYRE3.SA balance_sheet (annual, 2023-12-31) — Taxes Receivable: 10041000.00
CYRE3.SA cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -141651000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Total Assets: 17371200000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Total Capitalization: 11442409000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Total Debt: 5157538000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 8499826000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Total Expenses: 5423037000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 8871374000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 7602792000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 5416990000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 1125439000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Total Other Finance Cost: 45459000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Total Tax Payable: 50559000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Total Unusual Items: 25901000.00
CYRE3.SA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 25901000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 486836000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 24822195.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Treasury Stock: 308737000.00
CYRE3.SA balance_sheet (annual, 2023-12-31) — Working Capital: 6314024000.00
CYRE3.SA cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: 0.00
CYRE3.SA balance_sheet (quarterly, 2024-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 25754000.00
CYRE3.SA balance_sheet (quarterly, 2024-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 26720000.00
CYRE3.SA cash_flow (quarterly, 2024-09-30) — Purchase Of Intangibles: -4844000.00
CYRE3.SA cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -34022000.00
CYRE3.SA income_statement (annual, 2024-12-31) — +Operating Expense: 1282535000.00
CYRE3.SA income_statement (annual, 2024-12-31) — +Total Revenue: 7965688000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Accounts Payable: 248694000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3700652000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -271640000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 2256462000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Basic Average Shares: 439332000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Basic EPS: 4.50
CYRE3.SA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 241792000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 6872000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Capital Expenditure: -180804000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Capital Stock: 3685000000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 531729000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3052594000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -223746000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Cash Equivalents: 374948000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Cash Financial: 156781000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 41854000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Change In Inventory: -1257282000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 111079000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 119956000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Change In Payable: 1104280000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -43458000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Change In Receivables: -1597371000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Change In Working Capital: -1575803000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Changes In Cash: 289937000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Common Stock: 3685000000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -223746000.00
CYRE3.SA cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -223746000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 8894662000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Construction In Progress: 0.00
CYRE3.SA balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 0.00
CYRE3.SA income_statement (annual, 2024-12-31) — Cost Of Revenue: 5385823000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Current Assets: 12115105000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Current Debt: 1005064000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1005064000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 136743000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Current Deferred Taxes Assets: 1118000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Current Deferred Taxes Liabilities: 184706000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Current Liabilities: 3702290000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Current Provisions: 81138000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Deferred Tax: 135735000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Depreciation: 50815000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 50815000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Diluted Average Shares: 439332000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Diluted EPS: 4.50
CYRE3.SA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 1648996000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Dividends Payable: 391637000.00
CYRE3.SA balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 391637000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 188846000.00
CYRE3.SA income_statement (annual, 2024-12-31) — EBIT: 2564745000.00
CYRE3.SA income_statement (annual, 2024-12-31) — EBITDA: 2615560000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — End Cash Position: 531729000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Financing Cash Flow: 311365000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Finished Goods: 4763287000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Free Cash Flow: -117355000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -549914000.00
CYRE3.SA income_statement (annual, 2024-12-31) — General And Administrative Expense: 334559000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Goodwill: 141949000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 147564000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Gross PPE: 160302000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Gross Profit: 2579865000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 33911000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Interest Expense: 458263000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 458263000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Interest Income: 28819000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Interest Income Non Operating: 28819000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -460908000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Inventory: 4763287000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Invested Capital: 14869242000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -84877000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 2256462000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Issuance Of Debt: 3973024000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Long Term Debt: 4969516000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 4969516000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 3973024000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -3258605000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 3126325000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Long Term Provisions: 124209000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 8963000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Minority Interest: 1054612000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Minority Interests: -272056000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -152379000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Net Debt: 5442851000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Net Income: 1648996000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 1648996000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 1921052000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1648996000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1648996000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 2106482000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 1921052000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -38893000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Net Interest Income: -476041000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -92919000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 714419000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 714419000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -476041000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 131127000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Net PPE: 160302000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -141911000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 8747098000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 832258000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 965000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 460481000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Normalized EBITDA: 2644738000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Normalized Income: 1675605510.67
CYRE3.SA cash_flow (annual, 2024-12-31) — Operating Cash Flow: 63449000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Operating Income: 1297330000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Operating Revenue: 7965688000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 366532439.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Other Current Assets: 341930000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 383580000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Other Equity Interest: 18564000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 5615000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Other Non Cash Items: 806887000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1924872000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Other Operating Expenses: 232355000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Other Payable: 981256000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Other Properties: 144467000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 2520865000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Payables: 1693355000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 225291000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Prepaid Assets: 73984000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Pretax Income: 2106482000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Properties: 0.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 228732000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 5385823000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 50815000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Rent And Landing Fees: 17471000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 17471000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -3258605000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Retained Earnings: 0.00
CYRE3.SA balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 0.00
CYRE3.SA income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 449644000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Selling General And Administration: 784203000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Share Issued: 384000000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 8894662000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 8747098000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -2568489.33
CYRE3.SA income_statement (annual, 2024-12-31) — Tax Provision: 185430000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.09
CYRE3.SA balance_sheet (annual, 2024-12-31) — Taxes Receivable: 10886000.00
CYRE3.SA cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -161366000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Total Assets: 21240962000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Total Capitalization: 13864178000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Total Debt: 5974580000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 9949274000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Total Expenses: 6668358000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 11291688000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 9125857000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 7589398000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1992797000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Total Other Finance Cost: 46597000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Total Tax Payable: 71768000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Total Unusual Items: -29178000.00
CYRE3.SA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -29178000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 1202934000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 17467561.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Treasury Stock: 265309000.00
CYRE3.SA balance_sheet (annual, 2024-12-31) — Working Capital: 8412815000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — +Operating Expense: 362170000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — +Total Revenue: 1952744000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 286988000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3770590000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -273592000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 2490300000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 368539326.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Basic EPS: 0.89
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 531729000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 57245000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -35661000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 3685000000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 145454000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3012404000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 27499000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Cash Financial: 117955000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -18931000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Change In Inventory: -388558000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 49461000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 32752000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Change In Payable: 96161000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -26613000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Change In Receivables: -249528000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -524931000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -386275000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Common Stock: 3685000000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 9350228000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1318405000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Current Assets: 12383990000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Current Debt: 1003400000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1003400000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 84865000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Assets: 788000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 183477000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3682137000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Current Provisions: 78585000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Deferred Tax: 3703000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Depreciation: 21373000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 21373000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 368539326.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.89
CYRE3.SA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 327632000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 391637000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 131633000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — EBIT: 577621000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — EBITDA: 598994000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — End Cash Position: 145454000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -143174000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Finished Goods: 5053128000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -157543000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -194759000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 8938000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 98981000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Goodwill: 133050000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 139389000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 438521000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Gross Profit: 634339000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 37759000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Interest Expense: 139658000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 139658000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Interest Income: 4775000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 4775000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -94226000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Inventory: 5053128000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 15367686000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -121219000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 2490300000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 392077000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 5014058000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5014058000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 392077000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -478120000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 3066959000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 130726000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 56927000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Minority Interest: 1067258000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Minority Interests: -66181000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -3596000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Net Debt: 5872004000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Net Income: 327632000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 327632000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 393813000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 327632000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 327632000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 437963000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 393813000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -1157000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Net Interest Income: -138066000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -217191000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -86043000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -86043000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -138066000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 43161000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Net PPE: 164929000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -34504000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 9210839000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 67103000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 791726000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 988000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 467727000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 594443000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Normalized Income: 323536100.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -121882000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Operating Income: 272169000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Operating Revenue: 1952744000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 366310939.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 301357000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 371804000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 18564000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 6339000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 279321000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1986456000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 49757000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Other Payable: 960026000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Other Properties: 324349000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2866950000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Payables: 1695845000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 206360000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 100597000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Pretax Income: 437963000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 123566000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -1157000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -257431000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -34504000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1318405000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 21373000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 5297000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 5297000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -478120000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 327632000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 40240000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 130795000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 229776000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Share Issued: 384000000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 9350228000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 9210839000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 455100.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Tax Provision: 44150000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.10
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 22502000.00
CYRE3.SA cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -44555000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Total Assets: 21847715000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 14364286000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Total Debt: 6017458000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 10417486000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Total Expenses: 1680575000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11430229000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 9463725000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 7748092000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 3183000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 57194000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Total Unusual Items: 4551000.00
CYRE3.SA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 4551000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 1343855000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 17689061.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 268905000.00
CYRE3.SA balance_sheet (quarterly, 2025-03-31) — Working Capital: 8701853000.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — +Operating Expense: 379008000.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — +Total Revenue: 2107130000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 289242000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 3949072000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -283836000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 2788318000.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 366311822.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — Basic EPS: 1.06
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 145454000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 59504000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -48330000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3685000000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 178909000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 3267092000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 49826000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Cash Financial: 129083000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 21881000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Change In Inventory: -570212000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 121837000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -22140000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Change In Payable: -19445000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -650000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Change In Receivables: -226057000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -716995000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Changes In Cash: 33455000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Common Stock: 3685000000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 9786076000.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1417294000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Current Assets: 13227798000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Current Debt: 1194126000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1194126000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 85105000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Current Deferred Taxes Assets: 867000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Current Deferred Taxes Liabilities: 182226000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3935549000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Current Provisions: 77817000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Deferred Tax: 50025000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Depreciation: 13755000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 13755000.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 366311822.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.06
CYRE3.SA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 387807000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 391637000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 99918000.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — EBIT: 685585000.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — EBITDA: 699340000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — End Cash Position: 178909000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 25938000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 814046000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Finished Goods: 5432700000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -621427000.00
CYRE3.SA cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -234207000.00
CYRE3.SA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 96426000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Goodwill: 123003000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 128913000.00
CYRE3.SA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 463157000.00